By isolating these different profiles, Digbi Health can tailor treatment more precisely, leading to 3X better weight loss outcomes and 5X better drug tolerability than traditional one-size-fits-all GLP-1 lifestyle companion programs, which ignore the patient's biology, ethnicity, and gender
He argues for the importance of addressing digestive health, immune function, and overall body wellness to successfully manage cancer
HPV-positive HNSCC affects younger patients and demonstrates significantly improved survival compared to HPV-negative cases as evidenced by an up to 58% reduction in mortality, likely due to distinct biological and immunological characteristics 2,3
For this latest analysis, researchers tracked data from the SELECT trial, originally designed to examine semaglutides impact among overweight/obese patients without diabetes, and focused exclusively on more than 2,000 patients with a prior history of CABG